Plus500 Reports 11 Quarterly Revenue Growth Confirms FullYear Guidance ADIL Q1 2026 Earnings Narrowed Loss Beats Expectations as Biotech Advances Pipeline Arvind Sanger Maintains Cautiously Optimistic View on Indian Markets Focuses on Earnings Revival